Shenzhen, China, April 30, 2025 — The pharmaceutical sector is undergoing a significant digital shift, fueled by the widespread adoption of AI. Tencent Healthcare has introduced Next Generation Engagement Suite R4.0 (NGES R4.0) to assist global pharmaceutical companies in utilizing advanced AI for operations and expansion within the Chinese market.

NGES 4.0 utilizes AI to boost efficiency, enhance management, and ensure compliance in areas like multi-channel marketing, meeting organization, and Customer Relationship Management (CRM). The integration of large AI models positions NGES R4.0 to transform the pharmaceutical industry.

AI technology is rapidly permeating various sectors, including pharmaceuticals. Tencent Healthcare is addressing this trend by promoting intelligent development in the industry through large AI models and tools. The updated NGES R4.0 integrates AI into pharmaceutical digital marketing, enabling more targeted customer engagement and efficient resource management.

A key upgrade is the ability to switch between Tencent Hunyuan and DeepSeek models. This dual-model capability, combined with a refined pharmaceutical knowledge base, allows NGES R4.0 to help companies create professional academic content. It supports academic abstract generation, intelligent title optimization, and professional content expansion, while ensuring medical accuracy and compliance through a dual-track system incorporating a medical terminology library and manual review, increasing content production efficiency. Furthermore, this version automatically adapts to different academic styles, providing intelligent processing from draft to compliance verification and reducing labor costs.

NGES R4.0 also includes over 10 pre-set professional labels for diseases, drugs, and patient types via a medical master data tag system, enabling immediate intelligent annotation. By combining the rule engine of a medical knowledge base with the semantic understanding of large models, it can automatically analyze core elements from medical literature and patient education materials. Manual calibration is also supported to optimize label accuracy, achieving a 60% increase in accuracy compared to traditional models. The collaborative human-machine workflow further improves annotation efficiency and ensures the rigor of professional terms.

Beyond NGES R4.0, Tencent Healthcare offers AI solutions from cloud to local endpoints, supporting clinical trials, drug R&D, and medical translation. The introduction of distributed cloud and AI knowledge engines enables quick deployment and optimization of AI applications.

As AI continues to integrate into the pharmaceutical industry, companies need to adapt. Tencent Healthcare’s NGES R4.0 will empower global companies to leverage technology in the Chinese market, fostering a more intelligent and efficient future for the industry.

“`